We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry ...

Microsoft will increase the prices on multiple Microsoft 365 nonprofit products later this year, following a price increase in March for multiple M365 commercial products after a decade of updates ...

The four-pronged strategy begins with the acquisition of GSK's oncology portfolio, which includes all of its marketed products and late-stage candidates, for $14.5 billion, with a further $1.5 ...

Furthermore, GSK is well known for providing its brand products with a price in Egypt that can be a fraction of its regular price in the region. Of the top 20 multinational corporations working in ...

Is it any better than the incredibly popular Xiaomi M365 Pro it essentially replaces ... home and active products straight to your inbox. Both have an identical colour display.

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

AI productivity software, along with AI PCs, are the products that are bringing AI capabilities to the masses. Businesses and organizations are rapidly expanding their use of AI. Building ...

"My work pivots on making M365 products relevant in fast-growing digital economies. I craft experiences for user needs of growth, productivity, and community for the target user base SMB Segments ...

Wolff Olins has created the new brand identity for global healthcare company GSK (formerly GlaxoSmithKline), aiming to better express its focus on innovation. The agency was brought on board around 18 ...

(Reuters) - Shares of GSK rose as much as 6.5% on Thursday after the British drugmaker agreed to pay up to $2.2 billion to ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...